Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Broccoli, Alessandro"'
Publikováno v:
Best Practice & Research Clinical Haematology. 31:241-250
The unique biological features of primary mediastinal large B-cell lymphoma are offering suggestions for the development and application of innovative drugs in patients who do not respond to first-line regimens or relapse. This lymphoma, in fact, is
Autor:
Alessandro Pulsoni, Barbara Botto, Alessandro Re, Manuel Gotti, Michele Spina, Luigi Rigacci, Andrea Evangelista, Sofia Kovalchuk, Daniela Gioia, Lara Mannelli, Manjola Dona, Luca Nassi, Benedetta Puccini, Alessandro Broccoli, Caterina Stelitano, Flavia Salvi, Armando Santoro, Chiara Pagani, Pier Luigi Zinzani, Maurizio Bonfichi
FDG-positron emission tomography (PET) performed early during therapy in advanced Hodgkin lymphoma patients has been confirmed as being important for progression-free survival. A group of patients with a negative interim-PET (i-PET) showed a positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05cb996a2f3f72571286dbb535a49edb
http://hdl.handle.net/11573/1347613
http://hdl.handle.net/11573/1347613
Publikováno v:
Hematology/Oncology Clinics of North America. 31:223-238
Angioimmunoblastic T-cell lymphoma is a follicular T-helper–derived neoplasm displaying a peculiar morphologic appearance and biological complexity. New mutations have been described that contribute to elucidating the underlying pathogenetic events
Publikováno v:
Best Practice & Research Clinical Haematology. 30:149-157
Efficacy, safety and mechanisms of action of novel agents in marginal zone lymphoma patients, both with a nodal and extranodal presentation, are reviewed. Data on lenalidomide, bortezomib and 90yttrium-ibrutumomab tiuxetan are obtained from trials sp
Autor:
Lisa Argnani, Pier Luigi Zinzani, Claudio Agostinelli, Letizia Gandolfi, Cinzia Pellegrini, Alessandro Broccoli
Publikováno v:
Tumori Journal. 102:S124-S127
Background Autoimmune manifestations may occur in patients with hairy cell leukemia (HCL), and some rare cases of polyarteritis nodosa and leukocytoclastic vasculitis have been reported. However, data regarding the treatment of these cutaneous manife
Autor:
Caterina Stelitano, Alessandro Levis, Antonio Castagnoli, Gian Mauro Sacchetti, Daniela Gioia, Giovannino Ciccone, Vincenzo Pavone, Umberto Vitolo, Lisa Argnani, Ercole Brusamolino, Maurizio Bonfichi, Andrea Evangelista, Flavia Salvi, Roberto Freilone, Pier Luigi Zinzani, Gianluca Gaidano, Armando Santoro, Umberto Ricardi, Francesco Zaja, Giuseppe Rossi, Chiara Rusconi, Luigi Rigacci, Monica Tani, Eugenio Borsatti, Alessandro Pulsoni, Antonella Anastasia, Alessandro Broccoli, Patrizia Pregno
Publikováno v:
Journal of Clinical Oncology. 34:1376-1385
Purpose The clinical impact of positron emission tomography (PET) evaluation performed early during first-line therapy in patients with advanced-stage Hodgkin lymphoma, in terms of providing a rationale to shift patients who respond poorly onto a mor
Autor:
Claudio Agostinelli, Pier Luigi Zinzani, Lisa Argnani, Laura Nanni, Michele Cavo, Alessandro Broccoli, Vittorio Stefoni
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
Background No standard of care is established for plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemotherapy and display resistance to commonly applied cytostatic drugs. Case presentation W
Autor:
Pier Luigi Zinzani, Beatrice Casadei, Lisa Argnani, Federica Quirini, Alice Morigi, Miriam Marangon, Vittorio Stefoni, Alessandro Broccoli, Cinzia Pellegrini, Lorenzo Tonialini
Publikováno v:
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Background The purpose of this study is to investigate the most suitable first-line approach and the best combination treatment for primary mediastinal large B-cell lymphoma (PMLBCL) as they have been matter of debate for at least two decades. Method
Publikováno v:
Blood. 129(9)
Peripheral T-cell lymphoma, not otherwise specified, is a broad category of biologically and clinically heterogeneous diseases that cannot be further classified into any other of the existing entities defined by the World Health Organization classifi
Autor:
Caterina Stelitano, Waldemar Kulikowski, Alessandra Romano, Lisa Argnani, Luigi Rigacci, Alessandro Levis, Fabio Fuligni, Pier Paolo Piccaluga, Anna Borra, Randy D. Gascoyne, Francesco d'Amore, Bogdan Małkowski, Claudio Agostinelli, Edyta Subocz, Stefano Pileri, Pier Luigi Zinzani, Livio Trentin, Luisa Stracqualursi, Maria Teresa Sista, Stephen Hamilton-Dutoit, Caterina Patti, Claudio Tripodo, Andrea Gallamini, Jan Maciej Zaucha, Alessandro Broccoli, Stefano Fanti, Francesco Merli, Alberto Biggi, Christian Steidl, Justyna Rybka, Umberto Vitolo, Joanna Tajer, Patrizia Agati, Peter Kamper
Publikováno v:
Agostinelli, C, Gallamini, A, Stracqualursi, L, Agati, P, Tripodo, C, Fuligni, F, Sista, M T, Fanti, S, Biggi, A, Vitolo, U, Rigacci, L, Merli, F, Patti, C, Romano, A, Levis, A, Trentin, L, Stelitano, C, Borra, A, Piccaluga, P P, Hamilton-Dutoit, S, Kamper, P, Zaucha, J M, Małkowski, B, Kulikowski, W, Tajer, J, Subocz, E, Rybka, J, Steidl, C, Broccoli, A, Argnani, L, Gascoyne, R D, d'Amore, F, Zinzani, P L & Pileri, S A 2016, ' The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma : a retrospective, European, multicentre cohort study ', The Lancet. Haematology, vol. 3, no. 10, pp. e467-e479 . https://doi.org/10.1016/S2352-3026(16)30108-9
BACKGROUND: Early-interim fluorodeoxyglucose (FDG)-PET scan after two ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy courses (PET-2) represents the most effective predictor of treatment outcome in classical Hodgkin's lymphom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e938ba130f6b8eebdc3e9dca76c61cbe
https://hdl.handle.net/20.500.11769/542314
https://hdl.handle.net/20.500.11769/542314